Physician profile
Kendra E Simpson
NPI 1811282643
$1,131.05
in general payments reported to CMS, 2019-2025
13 companies · $83.43 in 2025
The $83.43 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $194 · 2021: $157 · 2022: $127 · 2023: $116 · 2024: $105 · 2025: $83.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $281.51 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $207.12 | 2019-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Sanofi Pasteur INC. | $195.38 | 2019-2025 | |
| Genentech USA, INC. | $155.92 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $69.30 | 2019-2020 | |
| Kaleo, INC. | $65.67 | 2021-2022 | |
| Sobi, INC | $42.38 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $32.83 | 2019 | |
| Corium, LLC | $21.78 | 2022 | |
| Biomerieux INC | $19.00 | 2024 | Biofire Spotfire Respiratory (R) Panel |
| Neos Therapeutics, Lp | $14.87 | 2019 | |
| Tris Pharma INC | $14.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.